Capecitabine

ATC CODE

  • L01BC06

NEMLC Recommendation 1

INDICATION

  • Relapsed metastatic breast cancer failing an anthracycline and a taxane.

NEMLC RECOMMENDATION

  • Not Approved

REVIEW INDICATORS

  • Price

DATE RATIFIED

  • 15 September 2016

NEMLC Recommendation 2

INDICATION

  • Metastatic colorectal – first-line.

NEMLC RECOMMENDATION

  • Approved (as part of the XELOX regimen )

REVIEW INDICATORS

  • Availability of data for alternative oral fluoropyrimidines
  • Price increases not commensurate with approved SEP increases

DATE RATIFIED

  • 27 November 2008

NEMLC Recommendation 3

INDICATION

  • First-line therapy for advanced stomach/gastro-oesophageal junction cancer.

NEMLC RECOMMENDATION

  • Approved

REVIEW INDICATORS

  • None

DATE RATIFIED

  • 27 July 2014